Nano based drug delivery systems: recent developments and future prospects
By J. Patra, Gitishree Das, L. Fraceto, E. Campos, M. D. P. Rodriguez-Torres, L. Acosta-Torres, L. Díaz-Torres, R. Grillo, M. K. Swamy, Shivesh Sharma and 2 more. Journal of Nanobiotechnology, 2018
5,098 citations recorded by the source corpus.
Nanomedicine and nano delivery systems are a relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. Recently, there are a number of outstanding applications of the nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents etc.) in the treatment of various diseases. The current review, presents an updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and selective diagnosis through disease marker molecules. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications are also discussed. In addition, we have included information regarding the trends and perspectives in nanomedicine area.
Subfields: Biomaterials, Materials Chemistry, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/bab4f59b8d669f432ee94d13005c46f36cd15ea5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- Seeram Ramakrishna
- Shivakalyani Adepu
- S. Kundu
- Nandana Bhardwaj
- Benjamin S. Hsiao
- W. Teo
- Benjamin Chu
In Materials Chemistry
In Pharmaceutical Science
Citations in the corpus
- Advances in drug delivery systems, challenges and future directions (2023, background): “Selectivity of ligands to target cells, immunogenicity, and chances of lysosomal degradation after macrophage endocytosis still pose solid challenges to the full development of actively targeting Drugs [23].”
- Therapeutic Nanoparticles and Their Targeted Delivery Applications (2020, neutral): “Ryanodex® Dantrolene sodium Dantrolene Malignant hyperthermia FDA 2014 [100]”
- Controlled Drug Delivery Systems: Current Status and Future Directions (2021, background): “These are originally solid colloidal particles of less than 100 nm comprising of macromolecules in which drugs can be entrapped or chemically bonded (covalent bond) to attain physical stability of the drug and to achieve controlled release property [86].”